logo

Detalhes dos produtos

Created with Pixso. Para casa Created with Pixso. produtos Created with Pixso.
Testes da doença infecciosa
Created with Pixso.

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

Nome da marca: ALLTEST
Número do modelo: IRSC-502
Informações pormenorizadas
Lugar de origem:
CHINA
Certificação:
CE
Precisão:
VSR: 96,1% SARS-CoV-2: 98,2%
Tempo de leitura:
15 minutos
Condições de armazenamento:
2-30°C
OEM:
Disponível
Jogo do teste:
10t
Formatar:
Cassete
espécimes:
Cotonete Nasopharyngeal
Descrição do produto

The RSV and SARS-CoV-2 Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of RSV and SARS-CoV-2 infectious diseases in human nasopharyngeal swab specimens as an aid in the diagnostic of RSV and SARS-CoV-2 infectious diseases.

 

RSV (Respiratory Syncytial Virus) and SARS-CoV-2 (the virus that causes COVlD-19) areboth highly contagious respiratory viruses, but they affect populations differently. RSV isa leading cause of severe respiratory illness in infants and older adults, while SARS-CoV-2has caused a global pandemic affecting all age groups. Symptoms of RSV often resemblea common cold but can escalate to bronchiolitis or pneumonia, characterized by severecough, wheezing, and difficulty breathing. In contrast, SARS-CoV-2 infection (COVID-19)presents with a wider range of symptoms, including fever, cough, fatigue, and loss ottaste or smell. While many cases are mild, it can lead to severe pneumonia, acute respira-tory distress syndrome (ARDS), and systemic complications.

 

Product Advantages:
Fast Results in 15 Minutes
High Accuracy
Easy Visual Interpretation
Convenient Procedure

 

Format Cassette Specimen Nasopharyngeal Swab
Certificate CE Reading Time 15 minutes
Storage Temperature 2-30°C Sensitivity RSV: 93.2% SARS-CoV-2: 96.4%
Specificity RSV: 98.1% SARS-CoV-2: 99.0% Accuracy RSV: 96.1% SARS-CoV-2: 98.2%
Pack 10 T